This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
This week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN.
2025 was rich in successful stories. Here are the top 10 that impressed our audience.
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
The full filtrate met last week to chat up CREDENCE. Hear the podcast on the web, or subscribe with the following feed link:
http://nephjc.com/freelyfiltered?format=rss
Now with more realistic cover art
This visual abstract is by NSMC Intern, Mario Funes
Here is the visual abstract from The George Institue
